We write with respect to various news articles relating to GMA Network, Inc. (“GMA7” or the “Company”). In the attached article entitled “GMA Ventures, TNB Aura ink partnership with RockMedical” posted in gmanetwork.com on September 27, 2024, it was reported that: “GMA Ventures Inc. and TNB Aura signed an investment deal with RockMedical. GMA Ventures Inc. (GVI) and TNB Aura are co-leading an investment fund round in Hofer Development Corporation (HDC), a company that develops over-the-counter healthcare and wellness products. GVI is the investment and diversification arm of GMA Network, while TNB Aura is a Singapore-headquartered venture capital company that focuses on Southeast Asia. Meanwhile, HDC operates under the brand RockMedical and is a fast-moving consumer goods company whose products are sold in over 10,000 stores all across the Philippines. The three companies signed the investment deal on September 26 at the GMA Network Center. ‘First, we'd like to welcome Hofer Development Corporation as the newest addition to GMA Ventures' portfolio of companies. We're very happy that you're joining us and thank you very much for trusting GMA Ventures to be a partner in your company. Second, we'd like to thank TNB Aura. TNB Aura was our first investment when we started. We've had a very fruitful partnership with TNB Aura. This is the first funding round that we are co-leading together with TNB Aura, the first of many,’ said Regie C. Bautista, President and Chief Operating Officer of GMA Ventures. . . . . HDC is the fourth start-up company joining the portfolio of GMA Ventures. Both GMA Ventures and TNB Aura found the investment strategic and timely as the market for health and wellness products is thriving and poised for continued growth. This is to confirm the above-mentioned report and statement attributed to GMA Ventures, Inc (GVI) President and Chief Operating Officer (COO) Regie C. Bautista. GVI, a wholly owned subsidiary of GMA Network, Inc (GMA7) entered into a convertible loan agreement (CLA) with Hofer Dev’t Corporation (HDC), operating under the brand RockMedical. The total aggregate amount of the CLA is USD500,000, with GVI investing USD250,000. TNB Aura, a Singapore-headquartered venture capital fund, invested the other USD250,000. GVI and TNB Aura executed separate CLAs with HDC. The loan is maturing 12 months from the completion date of the transaction. The agreed interest is 6% per annum on a non-compounded basis. Prior to the maturity date and within 6 months of the completion date (or another date agreed by GVI, TNB Aura, and HDC), the loan amount will be convertible to preferred securities issued by HDC at USD15.50 per share. |